SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-07-189172
Filing Date
2007-08-27
Accepted
2007-08-24 20:18:01
Documents
7
Period of Report
2007-08-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 21138
2 PLACEMENT AGENCY AGREEMENT dex11.htm EX-1.1 167422
3 FORM OF SUBSCRIPTION AGREEMENT dex12.htm EX-1.2 47139
4 FORM OF COMMON STOCK PURCHASE WARRANT dex41.htm EX-4.1 63423
5 OPINION OF STRADLING YOCCA CARLSON & RAUTH dex51.htm EX-5.1 13550
6 PRESS RELEASE dex991.htm EX-99.1 7953
7 GRAPHIC g94455logo.jpg GRAPHIC 9915
  Complete submission text file 0001193125-07-189172.txt   335930
Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718
Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-16467 | Film No.: 071079424
SIC: 2834 Pharmaceutical Preparations